Press Releases

Date	Title and Summary	View
Dec 01, 2016	Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey's Technology Business Tax Certificate Transfer Program PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company announced today that it has received net proceeds of approximately $3 million in non-dilutive financing through the State of New Jersey's Technology Business
Nov 07, 2016	Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial Top-Line Data Expected in Early January 2017; Resubmission Planned for First Half 2017 Cash Expected to Fund Operations Through the End of 2017 PRINCETON, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company, today
Aug 08, 2016	Agile Therapeutics Reports Second Quarter 2016 Financial Results Twirla® Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017; Cash Expected to Fund Operations Through the End of 2017
Jul 28, 2016	Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors Industry Veteran Brings Significant Management and Commercial Experience
Jul 12, 2016	Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline Preparations Underway for Phase 2 Clinical Trial of Novel Twirla® Line Extension
Jul 06, 2016	Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer Appoints Former Senior J&J Executive responsible for leading launch of ORTHO EVRA®
Jun 23, 2016	Agile Therapeutics to Present at the Cantor Fitzgerald's 2nd Annual Healthcare Conference Presentation Scheduled on Wednesday, July 13th, 2016 at 1:00 PM ET
Jun 16, 2016	Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System
Jun 07, 2016	Agile Therapeutics to Present at the William Blair & Company's 36th Annual Growth Stock Conference Presentation Scheduled on Tuesday, June 14th, 2016 at 2:50 PM Central Time
Jun 02, 2016	Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference Presentation Scheduled on Friday, June 10th, 2016 at 10:30 AM Eastern Time